| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_659c317ed4cb50f66ac7fe400027898d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4723 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K9-00 |
| filingDate |
2006-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5874c712eb47878f466399aa43cc9996 |
| publicationDate |
2010-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010016546-A1 |
| titleOfInvention |
Therapeutic Peptide-Polysaccharide Biomaterials |
| abstract |
Peptide-polysaccharide conjugates may be created by linking at least one peptide to a polysaccharide. The peptide may be a defensin having at least a portion of the amino acid sequence of human-β-defensin-3. The portion may be the last 10-14 residues of the amino acid sequence. The polysaccharide may be functionalized with at least one R group prior to the linkage to aid in the linkage. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010048469-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8835380-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8691945-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012035310-A3 |
| priorityDate |
2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |